FIELD: medicine.
SUBSTANCE: the present innovation refers to the compositions of water-soluble propophol promedicines composed upon water foundation being resistant at room temperature for prolonged period of time which include water-dissolved efficient quantity of propophol promedicine and efficient quantity of antioxidant acting as a stabilizing agent chosen out of monothioglycerol and EDTA that enables not to apply harmful co-solvents or surface-active substances for preparing the composition in question.
EFFECT: higher efficiency.
11 cl, 5 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING WATER SOLUBLE PROPOPHOL PRODRUGS AND USES THEREOF | 2003 |
|
RU2297216C2 |
| PROPOFOL-CONTAINING COMPOSITION WITH ENHANCED ANTIBACTERIAL EFFECT | 2001 |
|
RU2244545C2 |
| METHOD FOR PREPARING WATER-SOLUBLE PHOSPHONOOXYMETHYL DERIVATIVES OF ALCOHOL AND PHENOL | 2002 |
|
RU2310659C2 |
| EMULSIONS "OIL-IN-WATER" CONTAINING PROPOFOL AND EDETATE | 1995 |
|
RU2147432C1 |
| ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470908C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470907C2 |
| MICROCOLLOIDAL SOLUTION OF PROPOFOL FOR ANAESTHESIA | 2013 |
|
RU2535001C1 |
| WATER-SOLUBLE PHOSPHONOOXYMETHYL ESTERS OF HINDERED ALCOHOLS AND PHENOLS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD FOR ANESTHESIA AND METHOD FOR TREATMENT OF TUMOR DISEASES | 1999 |
|
RU2235727C2 |
| PROPOFOL DELIVERY SYSTEMS | 2016 |
|
RU2709812C2 |
